Introduction {#sec1}
============

Precise regulation of RNA polymerase II (Pol II) transcription is critical for accurate gene activity. Gene expression is to a large degree regulated by distal regulatory elements called enhancers, which positively drive the expression of their targets in an orientation-independent, but highly temporal- and cell type-specific manner ([@ref114]).

In the past years, several high-throughput and computational prediction methods have been developed to annotate enhancers genome-wide. Many of them rely on the accepted evidence that enhancer activity is reflected genome-wide in accessible chromatin regions flanked by nucleosomes carrying the H3K27Ac modification and a higher proportion of H3K4me1 over H3K4me3 mark. Widely used algorithms and established computational pipelines, such as chromHMM ([@ref35]; [Table 1](#TB1){ref-type="table"}), can segment the genome in different chromatin states based on combinations of histone marks from ChIP-seq experiments and predict genomic regions corresponding to putative enhancers. Other methods rely on the overlap with transcription factor binding sites, such as p300, to define potential enhancers, or on signatures of nascent bidirectional RNA Pol II transcription ([@ref55]; [@ref4]; [@ref50]). These methods are usually accompanied by experimental pipelines to validate the enhancer potential on the predicted associated target gene expression, since only the computational annotation of a region as an enhancer does not ensure that this region enhances gene activity *in vivo*.

###### 

Glossary.

  **Term**    **Description**                                                                                                                                                                                                                                                                                                                                                                                                **References**
  ----------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------
  ChromHMM    Software developed to learn and characterize chromatin states, by integrating chromatin datasets, such as ChIP-seq of histone modifications. It employs a multivariate Hidden Markov model, which models the presence or absence of each histone mark.                                                                                                                                                         [@ref35]
  CAGE        Capped analysis of gene expression is a technique that maps the 5′ ends of capped RNA transcripts, thereby capturing transcription initiation sites genome-wide.                                                                                                                                                                                                                                               [@ref113]
  GRO-seq     Global run on sequencing is a technique that maps transcriptionally engaged RNA polymerase II (Pol II) genome-wide, capturing nascent RNA transcription. In this method, Pol II is allowed to run on in the presence of a labeled nucleotide analog (5′-bromouridine), which is incorporated into newly transcribed RNA.                                                                                       [@ref23]
  ATAC-seq    Assay for transposable accessible chromatin followed by deep sequencing is a technique that captures open chromatin sites. It is used to identify regions of open chromatin, such as nucleosome-free positions in regulatory regions. It is based on the transposition of sequencing adapters into native chromatin *in vitro*. Essentially, it probes chromatin accessibility using transposons *in vitro*.   [@ref14]
  STARR-seq   Self-transcribing active regulatory region sequencing measures enhancer activity (enhancer strength) genome-wide, by assaying candidate sequences from any source of DNA using a reporter system *in vitro*.                                                                                                                                                                                                   [@ref7]
  ChIA-PET    Chromatin interaction analysis by paired-end tag sequencing provides large-scale analysis of long-range chromatin interaction networks. In this technique, cross-linked chromatin interaction sites bound by specific proteins are enriched by chromatin immunoprecipitation, and the remote DNA elements interacting in close spatial proximity are connected through proximity ligation.                     [@ref38], [@ref40]; [@ref39]
  TADs        Topologically associating domains are considered the basic organizational units of chromosome architecture, covering hundreds of kilobases to several million bases in length. DNA sequences within a TAD physically interact with each other more frequently than with sequences outside the TAD.                                                                                                             [@ref30]; [@ref97]
  Hi-C        Hi-C is based on chromosome conformation capture (3C) technique. It captures the 3D architecture of entire genomes, by coupling proximity ligation of DNA fragments tethered together in spatial proximity (enriched by crosslinking) with high-throughput sequencing, to produce genome-wide interaction maps.                                                                                                [@ref75]

Enhancers and gene promoters have been proposed to share similar organization, in terms of transcription initiation and transcription factor binding ([@ref22]; [@ref6]; [@ref63]), and functional properties, such as the pausing of Pol II ([@ref53]; [@ref121]). In addition, highly transcribed enhancers can act as weak promoters *in vivo* ([@ref94]; [@ref125]; [@ref87]) and a subset of promoters may intrinsically possess enhancer activity ([@ref73]; [@ref7]; [@ref133]; [@ref94]; [@ref28]; [@ref87]), suggesting that a dual enhancer-promoter activity has evolved at some regulatory sequence elements. In accordance, recent advancements of high-throughput genomics have set the ground to establish that enhancers are not just distal regulatory elements acting as binding platforms for proteins, but they are also actively transcribed, greatly contributing to the overall pervasive transcription observed in eukaryotic genomes ([@ref9]; [@ref29]; [@ref58]). Large-scale sequencing studies have revealed that \~75% of the human genome is transcribed, but only \~2% of this output is protein-coding RNA ([@ref59]; [@ref31]). The rest includes several species of non-coding RNA transcripts showing distinct degrees of stability and turnover, as well as different functions, although the specific roles of some non-coding RNA species are still not fully understood.

In this review, we will summarize data examining the role and functional implications of enhancer-associated non-coding RNA transcription and its products in transcription regulation of target gene expression, with a focus on stable long non-coding RNAs (lncRNAs)*.* We will discuss the findings of recent studies providing evidence that transcription-associated processes, including splicing, may have a functional impact on transcriptionally active enhancers producing lncRNAs, shaping the regulatory potential of the cognate enhancer on target gene expression.

Different types of non-coding RNA transcripts encoded in the human genome show distinct degrees of processing and stability {#sec2}
===========================================================================================================================

Enhancers display extensive RNA Pol II transcription in a bidirectional mode, giving rise to enhancer-associated non-coding RNA molecules, termed eRNAs, which were first described in high-throughput experiments and large-scale transcriptome analyses ([@ref26]; [@ref62]; [@ref66]). eRNAs are typically short, unspliced, and unstable, but based on their average detected length (\>100 nt), sometimes they are also classified into lncRNAs ([@ref96]). By definition, lncRNAs are molecules \>100--200 nt, which lack coding potential ([@ref58]). In the current human Gencode annotation ([@ref27]), lncRNAs consist of 10 subclasses, including 'lincRNAs', 'sense overlapping', 'antisense', and 'sense intronic' transcripts. The last three subclasses refer to lncRNAs overlapping other annotated transcription units in the same (sense) or antisense orientation, or found within introns of protein-coding genes (PCGs), respectively. lincRNAs refer to 'intergenic' lncRNAs, meaning not overlapping any other annotated transcription unit. lincRNAs are usually spliced and polyadenylated ([@ref124]) and thus rather stable. In fact, 84.5% of Gencode lincRNAs have at least one splicing junction.

lncRNAs can be identified starting by *de novo* transcript assembly in RNA-sequencing data using specialized algorithms like Cufflinks ([@ref122]) and StringTie ([@ref103]). These tools also allow the identification of splicing junctions and putative alternative splicing isoforms. The assembled transcription unit can be supported by available CAGE data ([@ref113]; [Table 1](#TB1){ref-type="table"}) indicating transcription initiation site. The coding potential of the assembled transcript is then assessed by tools like CPAT ([@ref128]) and PhyloCSF ([@ref76]), and transcripts with a protein-coding score above a given cutoff are filtered out. lincRNAs are further identified by excluding overlaps with known PCGs, while histone modification marks, like the promoter-associated H3K4me3, may also be employed to support the identification. For instance, for the automated annotation of lincRNAs included in the final Gencode datasets, Ensemble follows an established pipeline ([@ref45]) where firstly, regions of chromatin methylation (H3K4me3 and H3K36me3) outside known protein-coding loci are identified. Next, cDNAs that overlap with H3K4me3 or H3K36me3 features are identified as candidate lincRNAs. In the final evaluation step, candidate lincRNAs with substantial protein-coding potential (an open reading frame covering at least 35% of length and containing PFAM protein domains) are discarded.

eRNA as a term is not included in Gencode annotation; however, this does not preclude that many of the Gencode-annotated lncRNA transcripts may actually overlap enhancer-transcribed eRNAs in specific cell lines. Because of their rapid turnover by nuclear decay pathways employing the exosome activity ([@ref78]), eRNAs are not readily detectable in steady-state RNA-seq data, and therefore for their annotation nascent RNA-sequencing techniques like GRO-seq ([Table 1](#TB1){ref-type="table"}) or conditions of exosome depletion are employed ([@ref23], [@ref22]; [@ref48], [@ref49]; [@ref4], [@ref5]).

On the other hand, using actinomycin treatment and expression microarrays, [@ref20] showed that lncRNAs as a class cannot be characterized as unstable, since their median half-life (\~3.5 h) is comparable to mRNAs (\~5.1 h). They also showed that lincRNAs and antisense lncRNAs are more stable compared to intronic lncRNAs and that spliced lncRNAs are more stable compared to mono-exonic transcripts, demonstrating that splicing as a process contributes to overall transcript stability ([@ref54]). Recently, [@ref85] showed that Gencode-annotated mRNAs and lincRNAs with similar expression levels exhibit equal stability (half-lives), although lincRNAs as a class are overall less efficiently spliced compared to mRNAs. Yet, the authors do find a substantial fraction of lincRNAs showing efficient splicing and conserved splice junctions, which are enriched in functionally annotated lincRNAs ([@ref1]), like *FIRRE* ([@ref46]), *Xist* ([@ref17]), and *MIAT* ([@ref74]). This might imply that efficient splicing and the process of maturation are important for a subset of lncRNAs in order to exert their functional roles. This possibility may apply not only to lincRNAs, but also to other lncRNA subclasses as well. For instance, by inhibiting the core spliceosome component PRP8, [@ref82] showed that splicing of the *COOLAIR* lncRNA, overlapping and transcribed antisense to the *FLC* gene, is functionally important for sense gene transcription.

On the other extreme, mono-exonic or inefficiently spliced lncRNAs are more likely to be byproducts of the act of transcription having itself a regulatory role *in cis*. In support of this, for one of the first identified inefficiently spliced lncRNAs, *Airn*, overlapping the *Igf2r* gene in the antisense direction, it was experimentally validated that the act of transcription exerts a regulatory effect *in cis*, whereas the RNA product has no important function ([@ref71]). Adding to this, splicing may not be functionally necessary for the lncRNAs enriched in the chromatin fraction of the cell; lncRNAs tethered to chromatin may exert their function *in cis*, regulating gene expression through the act of their transcription and via mechanisms like transcriptional interference ([@ref117]) or by enhancing the binding of transcription factors to regulatory elements ([@ref115]).

Toward understanding the functional distinctions among different non-coding RNA transcripts produced at enhancers {#sec3}
=================================================================================================================

Apart from the relatively short, unstable, and unspliced bidirectional eRNAs ([@ref26]; [@ref62]; [@ref31]), a subset of enhancers transcribe unidirectional lncRNAs showing different characteristics in terms of splicing and stability ([@ref66]; [@ref83]; [@ref57]; [@ref42]; [@ref134]). In a previous study, using solely the H3K4me1 histone modification mark and the correlation of the H3K4me1 signal with cell type-specific expression of putative mRNA targets to predict enhancers ([@ref24]), it was estimated that about one third of Gencode-annotated lincRNAs overlap cell type-specific enhancers ([@ref126]). The Marques laboratory refers to these intergenic enhancer-associated lncRNAs as 'elincRNAs' ([@ref83]; [@ref134]). About half of the Marques elincRNAs (44%) are spliced, i.e. having at least one splice junction and more than one exon. Given the complexity of the transcriptional landscape at enhancers and that relatively little is known about the functional impact of the production of long, stable non-coding RNA transcripts on the enhancer activity, two recent studies have set out to unveil the functional distinctions of the different classes of lncRNA transcripts produced from active enhancers, using genome-wide computational approaches ([@ref42]; [@ref134]).

![Strategy used for enhancer annotation and identification of enhancer-associated lncRNAs. (**A**) The annotation of enhancers starts from the mapping of DHSs that reflect increased chromatin accessibility. CAGE ([@ref4]) and/or nascent RNA sequencing data like GRO-seq ([@ref49]) or PRO-seq ([@ref80]) are used to detect substantial Pol II transcription emanating bidirectionally from the DHS. The unstable eRNAs, which are short, non-spliced, and non-polyadenylated, are the products of bidirectional Pol II transcription activity at the enhancer and can be detected using *de novo* transcript assembly in GRO-seq data. Apart from Pol II and general transcription factors (GTFs) like CBP/p300 binding at the DHS, the presence of active histone marks like H3K27Ac and H3K4me1 validates the enhancer. eRNAs are terminated early by polyadenylation (pAS)-like signals and are rapidly turned over by the exosome; hence they are not readily detectable in steady-state RNA-seq data. (**B**) In some cases (estimated \~5% of active enhancers), Pol II transcription initiating intrinsically bidirectionally at active enhancers is preferentially elongated in one direction, most probably due to the accumulation of activating random mutations leading to enrichment of U1 sites and splicing signals, which suppress early pAS ([@ref131]; [@ref42]). The production of long, spliced, and polyadenylated lncRNAs, which are stable and thus readily detectable in steady-stade RNA-seq data, is associated with higher enhancer activity; the latter is reflected by increased chromatin accessibility (DHS) and enrichment of positive histone modifications, i.e. H3K27Ac (enhancer mark), H3K4me3 (promoter mark), and H3K36me3 (a hallmark of transcription elongation). (**C**) The genomic topology of the predicted active enhancer is also examined, and its position relative to anchor points of chromosomal loops is characterized from Pol II ChIA--PET interactions and/or TAD boundaries. One or more putative target genes are identified based on long-range 3D interactions, and induced effects on target gene expression are examined in conditions of enhancer perturbation, including genetic manipulation of the enhancer-associated lncRNA locus. (**D**) Flow diagram of the steps employed for enhancer annotation and enhancer-associated lncRNA identification.](mjz047f1){#f1}

Bidirectional Pol II transcription producing eRNAs is tightly associated with enhancer activity and is therefore considered a hallmark of active enhancers. Hence, it is increasingly being employed in enhancer annotation, usually in combination with signal of DNase I hypersensitivity that reflects elevated chromatin accessibility due to a more open and active chromatin environment ([@ref86]; [@ref4]; [@ref92]). Nascent RNA sequencing techniques, like GRO-seq ([@ref23]; [Table 1](#TB1){ref-type="table"}), map nascent RNA molecules produced from transcriptionally engaged RNA Pol II and can therefore be used to detect the short-lived eRNAs (not captured in steady-state RNA-seq data). Using GRO-seq data, [@ref42] annotated enhancers as regions displaying substantial bidirectional transcription around DNase I hypersensitivity sites (DHSs), discarding any overlaps with PCGs. These enhancers, termed eRNA-producing centers (EPCs), were validated to display canonical enhancer histone marks (high H3K4me1 and H3K27Ac signal) and were annotated in three ENCODE human cell lines and in mouse embryonic stem cells (mESCs). The authors computed the distance between each EPC and the closest Gencode lncRNA transcription start site (TSS) and found that \~5% of all EPCs have an lncRNA TSS within a distance \<0.8 kb. This implies that intrinsically bidirectional transcription originating at active enhancers ([@ref4], [@ref5]) is sometimes preferentially elongated and strengthened in one direction to produce a stable lncRNA transcript, perhaps by the unidirectional accumulation of random mutations that bring together transcription factor binding sites, splice sites and poly(A) sites. They termed these lncRNA-associated enhancers 'la-EPCs', and the rest 'na-EPCs'; the latter correspond to non-lncRNA-associated enhancers, producing solely bidirectional eRNAs, and constitute the majority of active enhancers. Notably, \>90% of the enhancer-associated lncRNAs are spliced. Essentially, all of them could be classified as intergenic (lincRNAs) per definition, as any overlap with PCGs was excluded in the first place in their analysis.

A different approach is utilized by [@ref134] to define a set of actively transcribed intergenic enhancers in mESCs, based on ENCODE chromHMM-annotated enhancers in the same cell line ([@ref10]) overlapping mESC-specific DHSs ([@ref88]) and a CAGE cluster indicating transcription initiation ([@ref37]). In agreement with [@ref42], they found that \~5% of the analyzed mESC transcribed enhancers overlap previously annotated lincRNAs expressed in mESCs ([@ref119]). They termed these intergenic enhancer-associated lncRNAs 'elincRNAs' to distinguish them from other mESC-expressed intergenic lncRNAs not overlapping enhancers. Because of the different initial methodologies employed to define the final working datasets of transcribed enhancers, the fraction of spliced (multi-exonic) enhancer-associated lncRNAs differs between the two studies: about half in [@ref134] vs. \>90% in [@ref42]. A schematic representation of the computational methodologies employed for the genome-wide annotation of transcribed enhancers is summarized in [Figure 1](#f1){ref-type="fig"}.

Both groups then set out to characterize the properties and the functional distinctions between the different classes of enhancers and non-coding RNA transcripts produced at enhancer loci. In particular, [@ref42] conducted a detailed analysis to distinguish between bidirectionally transcribed enhancers associated with lncRNA production (la-EPCs) and the rest majority of bidirectionally transcribed enhancers not associated with lncRNAs (na-EPCs). Similarly, [@ref134] focused on characterizing the functional impact of transcribed elincRNAs on their cognate enhancer activity. They also compared the functional properties of elincRNAs to other expressed lincRNAs not associated with a transcribed enhancer.

A first interesting finding in [@ref42] is that lncRNA-associated enhancers exhibit significantly higher signals of marks associated with enhancer activity, compared to the rest of bidirectionally transcribed enhancers (na-EPCs). These are increased transcription activity (GRO-seq), higher H3K27Ac---a hallmark of transcriptionally active enhancers---and higher ATAC-seq signal ([@ref14]; [Table 1](#TB1){ref-type="table"}) reflecting local chromatin accessibility. This result suggests that the production of lncRNAs may have a positive impact on enhancer activity. Intriguingly, this effect may be intrinsically encoded in the DNA sequences of the lncRNA-associated enhancers, as these also display higher STARR-seq signal ([@ref7]; [@ref89]; [Table 1](#TB1){ref-type="table"}) compared to the rest bidirectionally transcribed enhancers. Notably, lncRNA-associated enhancers are preferentially found at the anchor points of chromosomal loops, the latter identified by Pol II ChIA-PET ([@ref38], [@ref40]; [@ref39]; [Table 1](#TB1){ref-type="table"}), suggesting that these lncRNA-transcribing enhancers are more likely to form 3D contacts with distal loci encompassing putative target genes.

Related to this, it was previously reported that some disease/trait-associated lncRNAs showing enrichment in enhancer-like chromatin signatures (elevated H3K4me1 to H3K4me3 ratio) are enriched at the boundaries of TADs ([@ref120]; [Table 1](#TB1){ref-type="table"}). It was further suggested that these lncRNAs might promote intra-TAD chromosomal interactions, since their abundance (expression or RNA levels) correlates with the frequency of intra-TAD DNA--DNA contacts, the latter computed from Hi-C contact matrices ([@ref75]; [Table 1](#TB1){ref-type="table"}). Interestingly, TAD boundaries are the sites where chromosomal looping between enhancers and target gene promoters frequently occurs ([@ref118]; [@ref79]). In their following study, [@ref134] unveiled that this preferential location of enhancer-associated lncRNAs at TAD boundaries is strictly restricted to spliced lncRNAs. In particular, they found that transcription initiation regions of multi-exonic (spliced) enhancer-associated lncRNAs are significantly enriched at the anchors of chromosomal loops, when compared to all other enhancer-derived non-coding RNA transcripts (i.e. eRNAs and mono-exonic enhancer-associated lncRNAs) or to other lincRNAs expressed in mESC. The authors therefore suggested that multi-exonic, spliced enhancer-associated lncRNAs might be involved in shaping (or modulating) the local chromosomal architecture ([@ref134]).

In support of a linkage between potentially functional lncRNAs and higher order chromatin organization, [@ref2] found that the majority of a set of positionally conserved spliced lncRNAs, which are preserved in their genomic location relative to orthologous PCGs between mouse and human, are located at loop anchor points and TAD boundaries, showing enrichment of CTCF binding sites. In the same line, we recently identified in breast cancer cells a subset of spliced lncRNAs transcribed from active enhancers at the anchors of chromosomal loops to putative target genes. These enhancer-associated lncRNAs show significant correlation in expression with their putative targets, stressing their role in cognate enhancer activity. Intriguingly, this group of enhancer-associated lncRNAs is less enriched in the chromatin-associated RNA fraction, indicating that these molecules are less tethered to chromatin and that their chromatin dissociation may be important for potential downstream functions ([@ref98] and discussed in the last section).

[@ref42] also found enrichment of CTCF binding at the lncRNA-associated enhancers, which is considered a factor involved in the maintenance of chromosomal loops ([@ref130]), as well as differential binding of several proteins preferentially found at PCG promoters. In addition, a higher fraction of the lncRNA-associated enhancers bear the H3K4me3 promoter histone mark (compared to the rest bidirectionally transcribed enhancers), overall underscoring that lncRNA-producing enhancers harbor promoter characteristics ([@ref42]). This is in agreement with previous studies reporting that lncRNA transcription initiation regions show both promoter and enhancer characteristics ([@ref83]; [@ref6]). Notably, the promoter regions of the enhancer-associated lncRNAs show significant enrichment for DNA binding proteins that bind also to RNA (i.e. containing an RNA recognition motif; RRM), whereas they are depleted from chromatin-remodeling forkhead-domain proteins acting as pioneer transcription factors ([@ref19]; [@ref70]; [@ref116]). Based on that, the authors suggested that the lncRNA-producing enhancers may employ specific mechanisms for opening the local chromatin structure and initiate transcription; thereby cotranscriptional splicing of the associated nascent lncRNA transcript may play a role in reinforcing this process, as discussed in the last section of this review.

Splicing has a positive impact on enhancer activity {#sec4}
===================================================

A prominent distinguishing characteristic between the lncRNA-associated enhancers and the rest of the enhancers transcribing bidirectional transient eRNAs (na-EPCs), highlighted in [@ref42], is splicing. In fact, among the DNA binding proteins with an RRM enriched at the enhancer-associated lncRNA promoters several are RNA processing factors, including essential proteins involved in splicing, such as RBFOX2, SRSF1, and U2AF1. As a proxy for splicing activity, the authors used the exon density, defined as the number of exons of a transcript normalized to the locus length. They found a correlation between the exon density of the enhancer-transcribed lncRNAs and the density of DHSs and H3K27Ac signal at the same locus. This suggests that splicing is positively associated with the enhancer activity. Notably, the consequent effect of splicing on increasing chromatin accessibility is exerted on the broader enhancer region and not only on the lncRNA body transcribed part. Based on that, the authors suggested that the observed splicing-coupled stimulating effect on enhancer activity is more likely to be due to the recruitment of activating factors---either by the produced lncRNA transcript itself or by its transcription and associated processing---rather than by some local effect of Pol II elongation along the lncRNA body ([@ref42]).

Similarly, [@ref134] also observe a positive impact of enhancer-associated lncRNA splicing on cognate enhancer activity. In particular, using CAGE data to measure transcription initiation during different stages of embryonic neurogenesis, they found that changes in enhancer-associated lncRNA transcription positively correlated with changes in transcription of the closest PCG, the latter considered as a putative *cis* target. This correlation was significantly stronger for the spliced (multi-exonic) enhancer-associated lncRNAs, compared to their mono-exonic counterparts. In agreement, there seems to be a positive correlation between the number of exons of the enhancer-associated lncRNAs and the expression changes of their putative *cis* target genes, implying that the amount of splicing of the enhancer-associated lncRNAs may contribute to their *cis*-regulatory roles, impacting the regulatory potential of their cognate enhancer. In addition, in agreement with the findings by [@ref42], [@ref134] also find enrichment of H3K4me1, DHSs, and H3K27Ac signals in enhancers transcribing multi-exonic lncRNAs vs. mono-exonic ones, thereby strengthening the notion that splicing of lncRNAs contributes to enhancer activity.

In support of this, a significant enrichment of evolutionary conserved U1 splice sites is found at the lncRNA-associated enhancers and only in the direction downstream of the lncRNA TSS, similarly to what is observed downstream of a PCG TSS ([@ref42]). Overall, this suggests that evolutionary selection acts on splicing signals to promote the formation of spliced lncRNA transcripts at some enhancers (\~5% of transcribed enhancers). In agreement, [@ref134] find that mutations are selectively suppressed at splice sites of enhancer-associated lncRNAs and that their splice site flanking regions are enriched in conserved exonic splicing enhancers and U1 snRNP recognition motifs, when compared to other lincRNAs. In general, there is a significant difference in the GC content between exonic and intronic sequences of all multi-exonic lincRNAs (either transcribed from enhancers or not; [@ref111]; [@ref47]; [@ref134]), a feature observed also for mRNAs and implicated in promoting splice site recognition and splicing efficiency ([@ref3]).

The notion that conserved splice sites guide the processing of lincRNAs may seem on a first sight to come in contrast with previous studies reporting that lincRNAs as a class are overall less efficiently spliced compared to mRNAs ([@ref85]; [@ref90]). However, this does not apply to the enhancer-associated lincRNAs (elincRNAs), which show splicing efficiency comparable to mRNAs ([@ref134]). Finally, using a statistical genetics approach, [@ref134] analyzed the effect of nucleotide variants on elincRNA transcription/splicing, cognate enhancer, and putative target gene activity. They demonstrated that the decrease of elincRNA splicing due to mutations at splice junctions resulted in 90% of the cases in significant downregulation of their putative protein-coding target gene expression. These inferred causal relationships further validate the hypothesis that it is the RNA splicing important in strengthening enhancer function, rather than the enhancer activity being a cause for splicing ([@ref134]).

Experimentally derived data support a role of lncRNA splicing in regulation of gene expression and shaping enhancer functionality {#sec5}
=================================================================================================================================

Apart from the genome-wide approaches discussed in the previous sections ([@ref42]; [@ref134]), previous studies employing experimental strategies have provided significant support for the potential functional impact of lncRNA splicing in regulation of target gene expression and on enhancer activity.

[@ref82] analyzed the effect of antisense lncRNA splicing in the plant *Arabidopsis* flowering system: the *COOLAIR* lncRNA is transcribed antisense and overlapping the *FLC* gene, displaying a major promoter-proximal and an alternative distal polyadenylation site (the latter overlaps the sense *FLC* promoter). Analysis of a hypomorphic mutation in the core spliceosome component PRP8 (*prp8-6*) revealed elevated histone methylation in the *FLC* gene body (active histone mark H3K4me2) and upregulated *FLC* transcription. Interestingly, the *prp8-6* mutation did not affect the sense splicing events of *FLC* or two other control genes, but greatly inhibited the splicing of the unique short intron of the major (most abundant) antisense *COOLAIR* isoform. This splicing event is necessary to create the exon, which contains the proximal poly(A) site; hence in the *prp8-6* mutation, usage of the proximal poly(A) site is reduced, while usage of the distal alternative poly(A) site is relatively increased. These results could be recapitulated by mutating the proximal acceptor splice site of *COOLAIR*, which again led to reduced proximal poly(A) site usage, increased H3K4me2, and sense *FLC* transcriptional upregulation, confirming the role of antisense lncRNA splicing in sense gene transcriptional suppression. In particular, the essential splicing event is coupled with targeted 3′ end processing of the antisense *COOLAIR* proximal poly(A) site, which triggers histone demethylase activity at the locus in an as yet mechanistically unclear step ([@ref77]). Based on the findings by [@ref77] and [@ref82], the authors suggested that alternative splicing and targeted 3′ end processing of antisense lncRNA transcripts may comprise a common mechanism in regulation of gene expression, by modulating the overlapping sense gene transcription through cotranscriptional coupling processes associated with repressive chromatin modifications. Functional investigation of other antisense lncRNAs in different systems is expected to further support this notion.

Through experimental dissection it is also possible to address the important question whether it is solely the act of transcription and/or cotranscriptional splicing, or rather the mature lncRNA product that constitutes the important functional aspect of enhancer activity, in the case of enhancer-associated lncRNAs. These two possible functional components are not mutually exclusive. The same question is also urging to be resolved in the case of antisense lncRNAs that may be involved in regulation of gene expression *in cis* through transcriptional interference. [@ref117] uncoupled the act of transcription from the function of the lncRNA transcript by using siRNAs targeting different regions of the *GNG12-AS1* lncRNA. The authors demonstrated that transfection of siRNAs in human cell lines targeting the first exon of *GNG12-AS1*, near its TSS, causes downregulation of the lncRNA transcription, which is accompanied by a consequent transcriptional upregulation of the sense overlapping *DIRAS3* gene. The latter was profiled by an increase in Pol II binding and the active histone modifications H3K4me3 and H3K36me3. In contract, targeting other exons of *GNG12-AS1* (closer to its 3′ end) with siRNAs led only to depletion of the lncRNA isoforms through post-transcriptional gene silencing, without affecting its nascent transcription, and importantly had no effect on the overlapping sense *DIRAS3* transcription. Hence, the authors established that it is the act of transcription of the antisense lncRNA that causes transcriptional interference of the sense overlapping target gene ([@ref117]).

In a similar direction, aiming to distinguish between the *cis* and *trans* implicated functions of transcribed lncRNAs, [@ref33] employed genetic manipulation of 12 lncRNA loci, using CRISPR technology ([@ref21]; [@ref81]), to perform heterozygous knockouts in *129/castaneus* F1 hybrid mESC. This line contains a polymorphic site every \~140 bp, which allowed to distinguish between the two alleles and classify the lncRNA effects as *cis* or *trans*, based on whether the observed associated expression changes of nearby genes (within 1 Mb of the lncRNA locus) are on the same modified (*cis*) or on the unmodified (*trans*) homologous chromosome allele. When the observed target expression changes are restricted to the *cis* allele, this most probably reflects a direct local *cis*-regulatory effect from the lncRNA locus; on the other hand, when the observed expression changes involve both alleles, this most probably means that the lncRNA transcript itself (dissociated from the *cis* modified allele) exerts some downstream *trans* regulatory role(s). Depletion of five lncRNA promoters specifically affected the expression of nearby genes solely on the same allele (*in cis*); intriguingly, that was also the case by depleting six PCG promoters, suggesting that both non-coding and coding transcription units may contribute to shaping neighboring gene expression. This is well related to the general correlation observed in neighboring gene expression ([@ref106]; [@ref32]). The observed perturbation of *cis* regulation upon promoter depletion could be due to abolishment of essential promoter-associated DNA regulatory elements, due to impeding the process of transcription, or due to abolishment of the RNA transcript itself. To distinguish among these three possibilities, the authors introduced polyadenylation signals (PAS) 0.5--3 kb downstream of the TSS to terminate transcription early and abolish most of the RNA transcript, without affecting the promoter. Interestingly, insertion of the early PAS turned down completely transcription at the whole lncRNA locus and consequently abolished the lncRNA product; most probably, an early PAS inserted within the first intron prevents splicing, which in turn substantially reduces transcription. Importantly, despite abrogating both transcription and the lncRNA transcript product itself, insertion of the early PAS did not have an effect on the *cis* target gene, suggesting that essential DNA regulatory elements in the depleted lncRNA promoter-proximal region (\~750 bp) exert the *cis*-regulatory effect on the nearby gene. These broad lncRNA promoter regions did not show an enhancer-like H3K4me1 to H3K4me3 ratio, hence they would not be classified as enhancers based solely on this measure ([@ref51]; [@ref65]; [@ref31]; [@ref16]). Still, they seem to possess enhancer activity since they are regulating neighboring gene expression *in cis*, perhaps by containing binding sites for proteins recruiting histone modifiers and chromatin remodelers, which results in increased chromatin accessibility. This observation is also in line with additional reports supporting that promoters and enhancers share organizational and functional characteristics ([@ref73]; [@ref83]; [@ref6]; [@ref63]; [@ref109]) and that promoters may function as enhancers ([@ref73]; [@ref110]; [@ref7], [@ref8]; [@ref133]; [@ref94]; [@ref101]; [@ref107]; [@ref25]; [@ref28]; [@ref43]; [@ref87]) and *vice versa* ([@ref67]; [@ref94]; [@ref125]; [@ref87]).

In order to assess the effect of splicing in shaping the lncRNA functional potential, [@ref33] deleted the first 5′ splice site of the lncRNA *Blustr* using CRISPR in the same system. The functional coupling between splicing and transcription was well established in previous studies, demonstrating that promoter-proximal splice sites and the process of splicing can significantly enhance transcription ([@ref11]; [@ref36]; [@ref72]). Components of the spliceosome can directly enhance Pol II transcription initiation ([@ref69]) and elongation ([@ref36]), mechanistically explaining why and how splicing enhances gene expression ([@ref111]). In accordance, by depleting the first 5′ splice site of *Blustr*, [@ref33] reported a total reduction of the lncRNA transcription (using GRO-seq) and a consequent downregulation in neighboring gene expression (*Sfmbt2*). This demonstrates that the process of transcription at the lncRNA locus coupled with cotranscriptional splicing is functionally important for transcription regulation of the target gene. Since the process of splicing depends on direct interactions between the spliceosome and the nascent RNA transcript, the nascent lncRNA itself is required for target gene activation. However, this mechanism does not seem to involve specific primary sequences of the lncRNA, as progressive depletion of individual exons with CRISPR had no significant effect on target gene expression.

In a previous study, removing the splicing signal from the lncRNA *Haunt* by replacing the endogenous lncRNA locus with its cDNA sequence could not rescue its *cis*-regulatory function ([@ref132]). However, in this case, the possibility that essential DNA *cis*-regulatory elements in the omitted intronic sequences are depleted from the genetically modified lncRNA locus cannot be excluded. Therefore, CRISPR genetic manipulation employing depletion of genomic intervals (like promoter regions, exonic or intronic sequences) in independent experiments, complemented by carefully designed short deletions around individual splice sites and isolated sequence motifs, allows for a more thorough dissection and conclusive examination of an lncRNA locus of interest. Consequently, this enables to evaluate the functional importance of individual lncRNA elements and characterize mechanistic aspects of transcription regulation of target gene expression.

Possible mechanisms underlying the functional impact of lncRNA splicing on cognate enhancer and target gene activity {#sec6}
====================================================================================================================

Despite the genome-wide results and the experimental supportive data summarized in this review, which strongly implicate a role of enhancer-transcribed lncRNA splicing in shaping enhancer activity, the molecular mechanism(s) and underlying mechanistic details of this process are unknown. So far, some possible implicated scenarios exist that we will discuss here.

First of all, the lack of primary sequence conservation in the exonic lncRNA sequences of the enhancer-associated lncRNAs ([@ref83]; [@ref134]), or even the lack of conservation in their specific exon--intron structure ([@ref123]), may on a first sight shadow the evidence for a functional role of the lncRNA transcript itself in enhancer activity and *cis* regulation of target gene expression. The latter is established through detailed examination and experimental dissection of individual lncRNA loci ([@ref91]; [@ref129], [@ref127]; [@ref60]; [@ref99]; [@ref15]; [@ref44]; [@ref33]; [@ref98]). In the case of functionally characterized lncRNAs with virtually conserved functions such as *Xist*, a minimum primary sequence conservation is observed ([@ref93]; [@ref64]), although the overall lncRNA gene structure may be well conserved ([@ref12]; [@ref56]; [@ref112]). Similarly, the sequence motifs associated with splicing in enhancer-associated lncRNAs, including splice sites and exonic splicing enhancers, are evidently conserved ([@ref104]; [@ref111]; [@ref47]; [@ref95]; [@ref85]; [@ref134]), supporting that splicing is an important functional aspect of enhancer-associated lncRNAs. But how is this functional impact mechanistically exerted?

One possible scenario is that splice factors binding to the conserved lncRNA splice sites recruit in turn protein factors that remodel the chromatin structure in the broader locus, for instance through histone modifications ([Figure 2A](#f2){ref-type="fig"}; [@ref61]). Data from [@ref111] suggest a coupling mechanism between splicing and effected changes in chromatin organization. In this model, splicing affects chromatin through the recruitment of splice-coupled activating factors, such as the CHD1 and SWI/SNF chromatin remodelers, which in turn may modulate neighboring gene activity. A second possibility is that cotranscriptional splicing of the nascent lncRNA transcript has an indirect effect on the transcription activity of the locus, through a functional coupling between splicing and transcription, as described above ([@ref11]; [@ref36]; [@ref69]; [@ref72]; [@ref111]). This could involve interactions between the spliceosome and components of the transcriptional machinery ([@ref84]). Increased transcription and the process of transcription itself may then contribute to *cis* gene regulation by recruiting activating factors like histone modifiers and nucleosome remodelers, resulting in an overall chromatin opening of the locus and increased chromatin accessibility at *cis* target genes ([@ref32]). In support of this, impeding either transcription or splicing at the lncRNA gene via genetic manipulation led to reduction in the H3K4me3 promoter histone mark and a spreading of the repressive mark H3K27me3 at the neighboring gene locus ([@ref33]).

![Possible mechanisms explaining the functional impact of lncRNA splicing on enhancer activity. (**A**) Splicing factors cotranscriptionally engaged at the conserved lncRNA splice sites may in turn recruit activating factors like histone modification enzymes and chromatin remodelers, resulting in an overall chromatin opening of the locus and a positive effect on *cis*-gene regulation. This happens while the lncRNA is tethered on chromatin, at its site of transcription, during cotranscriptional processing. (**B**) Splicing permits dissociation of the nascent lncRNA transcript from chromatin, which in turn interacts with additional proteins contributing to spatial amplification of the *cis*-regulatory signal. The two distinct possible mechanisms are not mutually exclusive.](mjz047f2){#f2}

Cotranscriptional splicing as well as the 3′ end formation (cleavage and polyadenylation) are processes tightly coupled to transcription and required for the efficient dissociation of the nascent RNA transcript from the chromatin-associated site of transcription ([@ref102]; [@ref108]; [@ref100]; [@ref105]). Using splicing inhibiting morpholinos we recently showed that impeding the cotranscriptional splicing of an enhancer-associated lncRNA (*A-ROD*) leads to increased chromatin retention of the lncRNA transcript and has a consequent repressive effect on transcription of the target gene *DKK1* ([@ref98]). Therefore, splicing of the enhancer-associated lncRNA may also have some downstream effects mediated by the lncRNA transcript itself. Upon its dissociation from chromatin, the nascent lncRNA may interact with protein factors required and recruited for transcription regulation of target gene expression within the spatial 3D proximity of pre-established chromosomal loops ([@ref98]). The enhancer-transcribed lncRNA, upon its chromatin dissociation permitted by splicing, may also be involved in- and contribute to 'spatial amplification' of the *cis*-regulatory signal ([@ref34]). For instance, the chromatin-dissociated lncRNA could be bound by RRM-containing proteins, which bind also to DNA, and thereby get recruited to the promoters of genes within the spatial proximity of the enhancer ([Figure 2B](#f2){ref-type="fig"}). Consequently, this would contribute to a quasi-*cis* mode of gene regulation ([@ref98]). In this model, the overall primary sequence conservation of the lncRNA is not a necessity, as RRMs can be short and degenerate or can even be emerging in secondary structures formed locally in the nascent chromatin-dissociated lncRNA. These hypotheses are intriguing but need to be further verified by large-scale or more specific analyses, such as bioinformatics prediction of local secondary structure elements in enhancer-associated lncRNAs ([@ref41]), or by enrichment analysis of DNA/RNA-binding protein sites from the numerous available high-throughput data in public repositories.

Overall, the recent experimental and genome-wide derived results suggest that the feature of chromatin dissociation may be an additional functional aspect of enhancer-produced lncRNAs, and therefore understanding the dynamics, underlying molecular mechanism(s), and mechanistic details of this process may help to further characterize the functional distinctions among the various non-coding RNAs transcribed from active enhancers. For instance, whether there is an overall association between the degree of chromatin dissociation and the degree of splicing, and whether efficiently chromatin-dissociated enhancer-transcribed lncRNAs are more efficiently spliced compared to their chromatin-retained counterparts, are important questions to address.

An overview of the mechanistic scenarios involved in mediating the functional impact of lncRNA splicing on enhancer activity is presented in [Figure 2](#f2){ref-type="fig"}.

In addition, apart from splicing, other cotranscriptional processes associated/coupled with lncRNA transcription, like transcription termination and the formation of a mature 3′ end, might as well have a similar functional impact in shaping enhancer activity and contributing to *cis* gene regulation. In this direction, similarly to analyzing DNA motifs and the enrichment of transcription factor binding sites at the promoters of enhancer-associated lncRNAs ([@ref42]), characterizing the interactions of RNA-binding proteins with the nascent lncRNA transcripts and their functional impact in cotranscriptional RNA processes is urging. Therefore, in order to comprehensively design and pursue large-scale and long-term experimental analyses, the use of recently developed computational algorithms to predict RNA-binding protein interactions, and their specific application for predictions using RNA sequence-structure motifs, is of great importance ([@ref18]; [@ref52]; [@ref68]; [@ref13]). Such tools facilitate the analysis and characterization of functional RNA--protein interactions and create a meaningful starting dataset of potential candidates to further dissect their functions experimentally.

By combining and employing both experimental and computational strategies, locus specific genetic manipulation, and complementary large-scale analyses, future research is expected to comprehensively characterize the mechanistic details and functional impact of non-coding RNA transcription and its various products in the precise regulation of target gene expression. We have only started scratching the surface.
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